BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: $2.40M2011: -$3.91M2012: -$3.42M2013: -$4.90M2014: -$7.42M2015: -$8.54M2016: -$5.08M2017: -$5.00M2018: -$14.06M2019: -$23.00M2020: -$31.68M2021: -$24.54M2022: -$24.82M2023: -$21.44M2024: -$11.69M2025: -$9.95M-$9.95M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$9.95M+14.9%
2024-$11.69M+45.5%
2023-$21.44M+13.6%
2022-$24.82M-1.2%
2021-$24.54M+22.6%
2020-$31.68M-37.8%
2019-$23.00M-63.6%
2018-$14.06M-181.3%
2017-$5.00M+1.7%
2016-$5.08M+40.5%
2015-$8.54M-15.0%
2014-$7.42M-51.5%
2013-$4.90M-43.0%
2012-$3.42M+12.5%
2011-$3.91M-263.0%
2010$2.40M